European Council Approves First-Ever Analysis Of Drug Prices With Look At IP Rights 17/06/2016 by William New, Intellectual Property Watch 3 Comments The 28 European Union governments today gave final approval to a first-ever plan to analyse medicines competition in Europe, with reference to drug prices, generics and biosimilars, and intellectual property rights. The final version was watered down after what sources said was heavy industry lobbying, compared to a leaked version published in Intellectual Property Watch two weeks ago, but still retains some strong provisions regarding pricing and competition.
European Council Conclusions On Steps To Combat Antimicrobial Resistance 17/06/2016 by Intellectual Property Watch 1 Comment The 28 European Union member governments have concluded next steps for addressing antimicrobial resistance, with a strong emphasis on reducing use of antibiotics in animals, but also including a call for new business models.
Panels Brainstorm Ideas On Innovation And Drug Access 15/06/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment The quest of balance between encouraging medical innovation and the imperative of broad access to medicines has so far been elusive. Two Harvard University programmes jointly organised a workshop this week with the aim of encouraging a conversation between global health actors and see if some “outside the box” thinking is possible.
Amid Allegations Of IP Theft By Corporations, Local Kenyan Innovators React 10/06/2016 by Fredrick Nzwili for Intellectual Property Watch 3 Comments NAIROBI, Kenya – As start-up and innovation centres spring up across Africa, Kenya – which birthed the continent’s tech movement – is emerging as one of its leading innovation nuclei. But concerns are intensifying here that young inventors are losing their innovations to conglomerates, in what is alleged as intellectual property theft or abuse.
Kenya’s Fledgling Innovation Agency Could Be Dissolved 10/06/2016 by Maina Waruru for Intellectual Property Watch 1 Comment NAIROBI, Kenya — Kenya could disband its infant innovation agency and have its functions taken up by the state’s science, technology and innovation body, if changes suggested by the government to reform the science, technology and innovation (ST&I) sector are carried through.
Special Report: Roundup Of US Copyright Office Review Of US Law 08/06/2016 by Dugie Standeford for Intellectual Property Watch 1 Comment The United States Copyright Office is examining how provisions of the Digital Millennium Copyright Act (DMCA) and the 1976 Copyright Act are working and whether any changes, legislative or otherwise, are needed. Not surprisingly, there are broad differences of opinion among rights owners, public interest groups, users of copyrighted works and the high-tech community on both questions.
“Mozart 4.0” Program Seeks A Global IP And Innovation Culture 07/06/2016 by Dugie Standeford for Intellectual Property Watch Leave a Comment Cultural mindset plays a key role in determining how entrepreneurial a region will be and how effectively its intellectual property will be used, Ludovit Garzik, managing director of the Austrian Council for Research and Technology Development and Innovation Orbit said at an 11 May Oxfirst webinar. The goal is for different cultures to understand how each innovates, leading to global IP, Garzik said.
Rwanda Releases New Tariff Levels On IP, Signs UPOV 91 Biotech Rules 06/06/2016 by Hillary Muheebwa for Intellectual Property Watch Leave a Comment The government of Rwanda has revised the fees and cost to be paid for the registration of different categories of intellectual property rights. The changes mean lower fees for all types of IP rights, and gives more time to oppose registrations. Rwanda also enacted a law on seeds and plant varieties.
IP-Watch Seeking Writers In Brussels, Washington 03/06/2016 by Intellectual Property Watch, Intellectual Property Watch 1 Comment Intellectual Property Watch is seeking occasional Freelance Writers based in the Washington DC Metro area, San Francisco Bay area, and in Brussels or London. Writers will assist with reporting, writing and publishing stories on international intellectual property and innovation policymaking and law. We are looking for writers who are experienced with delivering multimedia content on a digital news platform and through social media.
Q&A With Erich Spangenberg On Patents And Drug Prices 03/06/2016 by Intellectual Property Watch 1 Comment Prices for drugs have long been a problem for developing countries but now have become out of reach for many in developed countries, sparking policy debates and efforts to address it. One of the top figures in the patent monetization business, industry maverick Erich Spangenberg offers a lively opinion on the underlying problem and how to fix it. To start? Stop granting patent extensions for minor changes.